Investigators at Harvard-affiliated Dana-Farber Cancer Institute reported Black and Hispanic patients who had poor-prognosis cancer were less likely than white patients to receive opioid medications.
A Harvard Chan School study reveals that buprenorphine-naloxone, a highly effective, evidence-based treatment for opioid use disorder, is difficult to access in states with high rates of death associated with opiates.
A University of Michigan-Harvard University summit brought experts from the two universities as well as outside organizations to consider ways to address the opioid epidemic.
Against a backdrop of recent jumps in drug overdose deaths and suicide, McLean Hospital psychologist R. Kathryn McHugh discusses the opioid crisis and increasing suicide deaths with the Gazette.
/
1
